Patents by Inventor Maxim Chudaev

Maxim Chudaev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Assay for identification of therapeutics targeting ternary complex formation in protein synthesis

Patent number: 10174358

Abstract: The present invention provides a novel assay that allows high-throughput screening of chemical compounds for the inhibition of binding between EF-Tu and tRNA.

Type: Grant

Filed: October 31, 2014

Date of Patent: January 8, 2019

Assignee: Rutgers, The State University of New Jersey

Inventors: Wlodek Mandecki, Emanuel Goldman, Maxim Chudaev
Assay for Identification of Therapeutics Targeting Ternary Complex Formation in Protein Synthesis

Publication number: 20150118678

Abstract: The present invention provides a novel assay that allows high-throughput screening of chemical compounds for the inhibition of binding between EF-Tu and tRNA.

Type: Application

Filed: October 31, 2014

Publication date: April 30, 2015

Inventors: Wlodek Mandecki, Emanuel Goldman, Maxim Chudaev

Assay for identification of therapeutics targeting ternary complex formation in protein synthesis

Assay for Identification of Therapeutics Targeting Ternary Complex Formation in Protein Synthesis